News
-
-
PRESS RELEASE
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech's Universal Registration Document 2024 with business development and financial statements is now available. Learn about the leading biopharmaceutical company's global presence and innovative solutions -
-
-
-
-
PRESS RELEASE
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting
Sartorius Stedim Biotech's Board proposes a dividend of 0.69 euros per share for the fiscal year 2024, with two new Board candidates named. AGM scheduled for March 25, 2025 -
-
-